114 related articles for article (PubMed ID: 21553905)
21. Dynamics of immobilized and native Escherichia coli dihydrofolate reductase by quasielastic neutron scattering.
Tehei M; Smith JC; Monk C; Ollivier J; Oettl M; Kurkal V; Finney JL; Daniel RM
Biophys J; 2006 Feb; 90(3):1090-7. PubMed ID: 16258053
[TBL] [Abstract][Full Text] [Related]
22. NMR solution structure of the antitumor compound PT523 and NADPH in the ternary complex with human dihydrofolate reductase.
Johnson JM; Meiering EM; Wright JE; Pardo J; Rosowsky A; Wagner G
Biochemistry; 1997 Apr; 36(15):4399-411. PubMed ID: 9109647
[TBL] [Abstract][Full Text] [Related]
23. Rational automatic search method for stable docking models of protein and ligand.
Mizutani MY; Tomioka N; Itai A
J Mol Biol; 1994 Oct; 243(2):310-26. PubMed ID: 7932757
[TBL] [Abstract][Full Text] [Related]
24. Detection of long-lived bound water molecules in complexes of human dihydrofolate reductase with methotrexate and NADPH.
Meiering EM; Wagner G
J Mol Biol; 1995 Mar; 247(2):294-308. PubMed ID: 7707376
[TBL] [Abstract][Full Text] [Related]
25. Cyclophilin-promoted folding of mouse dihydrofolate reductase does not include the slow conversion of the late-folding intermediate to the active enzyme.
von Ahsen O; Lim JH; Caspers P; Martin F; Schönfeld HJ; Rassow J; Pfanner N
J Mol Biol; 2000 Mar; 297(3):809-18. PubMed ID: 10731431
[TBL] [Abstract][Full Text] [Related]
26. Incorporating dynamics in E. coli dihydrofolate reductase enhances structure-based drug discovery.
Lerner MG; Bowman AL; Carlson HA
J Chem Inf Model; 2007; 47(6):2358-65. PubMed ID: 17877338
[TBL] [Abstract][Full Text] [Related]
27. Increasing methotrexate resistance by combination of active-site mutations in human dihydrofolate reductase.
Volpato JP; Fossati E; Pelletier JN
J Mol Biol; 2007 Oct; 373(3):599-611. PubMed ID: 17868689
[TBL] [Abstract][Full Text] [Related]
28. Molecular modeling study of dihydrofolate reductase inhibitors. Molecular dynamics simulations, quantum mechanical calculations, and experimental corroboration.
Tosso RD; Andujar SA; Gutierrez L; Angelina E; Rodríguez R; Nogueras M; Baldoni H; Suvire FD; Cobo J; Enriz RD
J Chem Inf Model; 2013 Aug; 53(8):2018-32. PubMed ID: 23834278
[TBL] [Abstract][Full Text] [Related]
29. Novel 5-substituted, 2,4-diaminofuro[2,3-d]pyrimidines as multireceptor tyrosine kinase and dihydrofolate reductase inhibitors with antiangiogenic and antitumor activity.
Gangjee A; Zeng Y; Ihnat M; Warnke LA; Green DW; Kisliuk RL; Lin FT
Bioorg Med Chem; 2005 Sep; 13(18):5475-91. PubMed ID: 16039863
[TBL] [Abstract][Full Text] [Related]
30. Fundamental and biotechnological applications of neutron scattering measurements for macromolecular dynamics.
Tehei M; Daniel R; Zaccai G
Eur Biophys J; 2006 Sep; 35(7):551-8. PubMed ID: 16868745
[TBL] [Abstract][Full Text] [Related]
31. Ligand-induced conformational changes in the crystal structures of Pneumocystis carinii dihydrofolate reductase complexes with folate and NADP+.
Cody V; Galitsky N; Rak D; Luft JR; Pangborn W; Queener SF
Biochemistry; 1999 Apr; 38(14):4303-12. PubMed ID: 10194348
[TBL] [Abstract][Full Text] [Related]
32. Calorimetric studies of ligand binding in R67 dihydrofolate reductase.
Jackson M; Chopra S; Smiley RD; Maynord PO; Rosowsky A; London RE; Levy L; Kalman TI; Howell EE
Biochemistry; 2005 Sep; 44(37):12420-33. PubMed ID: 16156655
[TBL] [Abstract][Full Text] [Related]
33. High-resolution structure of a plasmid-encoded dihydrofolate reductase: pentagonal network of water molecules in the D2-symmetric active site.
Narayana N
Acta Crystallogr D Biol Crystallogr; 2006 Jul; 62(Pt 7):695-706. PubMed ID: 16790925
[TBL] [Abstract][Full Text] [Related]
34. Dihydrofolate reductase binding and cellular uptake of nonpolyglutamatable antifolates: correlates of cytotoxicity toward methotrexate-sensitive and -resistant human head and neck squamous carcinoma cells.
Chen G; Wright JE; Rosowsky A
Mol Pharmacol; 1995 Oct; 48(4):758-65. PubMed ID: 7476904
[TBL] [Abstract][Full Text] [Related]
35. Structural comparison of chromosomal and exogenous dihydrofolate reductase from Staphylococcus aureus in complex with the potent inhibitor trimethoprim.
Heaslet H; Harris M; Fahnoe K; Sarver R; Putz H; Chang J; Subramanyam C; Barreiro G; Miller JR
Proteins; 2009 Aug; 76(3):706-17. PubMed ID: 19280600
[TBL] [Abstract][Full Text] [Related]
36. A large compressibility change of protein induced by a single amino acid substitution.
Gekko K; Tamura Y; Ohmae E; Hayashi H; Kagamiyama H; Ueno H
Protein Sci; 1996 Mar; 5(3):542-5. PubMed ID: 8868493
[TBL] [Abstract][Full Text] [Related]
37. Chemically induced self-assembly of enzyme nanorings.
White BR; Li Q; Wagner CR
Methods Mol Biol; 2011; 743():17-26. PubMed ID: 21553179
[TBL] [Abstract][Full Text] [Related]
38. Methotrexate gamma-hydroxamate derivatives as potential dual target antitumor drugs.
Santos MA; Enyedy EA; Nuti E; Rossello A; Krupenko NI; Krupenko SA
Bioorg Med Chem; 2007 Feb; 15(3):1266-74. PubMed ID: 17127067
[TBL] [Abstract][Full Text] [Related]
39. A bifunctional molecule that displays context-dependent cellular activity.
Braun PD; Barglow KT; Lin YM; Akompong T; Briesewitz R; Ray GT; Haldar K; Wandless TJ
J Am Chem Soc; 2003 Jun; 125(25):7575-80. PubMed ID: 12812497
[TBL] [Abstract][Full Text] [Related]
40. Ligand binding modulates the mechanical stability of dihydrofolate reductase.
Ainavarapu SR; Li L; Badilla CL; Fernandez JM
Biophys J; 2005 Nov; 89(5):3337-44. PubMed ID: 16100277
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
